Washington Post features Americans opting out of Obamacare

Sean Parnell of the Self-Pay Patient blog writes:

Nearly two and a half months ago, I posted here that a reporter had contacted me and waslooking for people to interview who had chosen to opt out of Obamacare. Several dozen of you responded, and I was able to pass along your information for her to include in her article.

The article finally ran last week in the Washington Post  (her editor had bumped it until after the end of Obamacare’s open-enrollment period, hence why it’s only now coming out), and I’m pleased to say I think the reporter did a good and fair job explaining what some Americans are doing.

More: Washington Post features Americans opting out of Obamacare.

Leave a comment

Filed under insurance, tax code, HSAs

As Expected, #ObamaCare Motivates Insurers to Shun the Sickest People

John R. Graham writes:

A patient with HIV/AIDS can expect to pay over $1,000 out of pocket for medicines, if he buys a policy on the ObamaCare health insurance exchange in Florida.

“woman-in-hospitalAffordable”? Surely not. This perceived injustice has caused legal activists to file a lawsuit against four insurers, which offer plans in the Florida exchange, alleging discrimination.

Readers of this blog know that we have long warned against this consequence of ObamaCare. Insurers are not allowed to charge premiums appropriate to applicants’ expected medical claims. …

An ObamaCare Silver policy must pay 70 percent of expected medical costs, while covering 100 percent of “preventive care” (as defined by the federal government). However, the plan is designed for the average patient. So, it is easy for a health plan to design a plan that imposes very high medical maintenance costs on very sick, chronically ill people. High co-payments or co-insurance for prescriptions is one obvious method.

Our prediction: There will be many more such lawsuits.

Read more: As Expected, ObamaCare Motivates Insurers to Shun the Sickest People | John Goodman’s Health Policy Blog | NCPA.org.

In February, Graham blogged about this article from The Hill, which reports: “Consumers who use specialty medications may face higher costs on ObamaCare’s marketplace plans, many of which include co-insurance rather than copayments for the drugs, a new analysis warned.”

Last week, Graham illustrated one more example of insurers avoiding sick patients, this time in relation to how insurers use ObamaCare subsidies:

[P]lans apply more of the subsidy to the deductible, somewhat less likely to apply it to specialist charges, and much less likely to apply it to the most expensive tier 4 drugs on the formulary. What this means is that generally healthy patients who go to see their primary-care physician occasionally, but need no specialist care or specialty prescriptions, are most likely to benefit from the cost-sharing reductions. Those who need specialist care and, especially,  tier 4 drugs will be less likely to benefit.

Back in 2010, Peter Suderman wrote about how insurers tailor their plans to attract the healthy & avoid the sick:

Indeed, because insurers will be limited in terms of how they can charge based on health risk factors, the new rules may encourage plan providers to avoid investing in resources that help the sick.

For example, a 1997 New England Journal of Medicine study looked at billing records for elderly Americans participating in Medicare HMOs in Florida. The study found that, despite exchange-like regulations guaranteeing access to any HMO plan and prohibiting insurer cherry picking (or “medlining,” as it’s sometimes called), insurance companies managed to lure in the healthiest—and cheapest—patients, while leaving the sickest, most expensive patients on publicly funded Medicare.

As does John Goodman, writing about community rating:

When premiums are regulated so that they cannot reflect expected costs, four things will happen:

  1. On the buyer side, people who are under-charged will over-insure and people who are over-charged will under-insure. This is basic economics. If the price you are asked to pay is artificially low, you will buy more than you otherwise would; if the price is artificially high, you will buy less. If you are sick and require a lot of medical care but can pay the premium ordinarily charged to a healthy enrollee, for example, you will likely choose the richest plan you can find.
  2. In order to avoid attracting high cost enrollees, health plans will respond by scaling back their benefits and their provider networks until the richest plans look pretty much like every other plan. In the individual market today, in most states you can buy a BlueCross plan that covers almost all doctors in your area and practically every hospital, including all the best hospitals. I predict those plans will never see the light of day inside the (ObamaCare) health insurance exchanges. See Monday’s Health Alert on the race to the bottom with respect to access to care.
  3. At the same time, health plans will seek to attract the healthy. Of course, to a certain extent they are doing that today. But with an electronic exchange in which healthy people tend to buy on price and sick people tend to buy on benefits and software that makes it easy to do those things, the insurers will be even more pressured to reconfigure their offerings to make them more attractive to the healthy and less attractive to people who need medical care.
  4. Finally, the perverse incentives do not end at the point of enrollment. They continue. Health plans will have perverse incentives to over-provide to the healthy (to keep the ones they have and attract more of them) and to under-provide to the sick (to avoid attracting more of them and encourage those they have to go elsewhere).

See also this Reuters article: “Chronically ill facing high drugs costs under U.S. health law“:

Insurers say they had to move toward greater cost-sharing due to higher prices for new drugs, some of which can cost more than $100,000 annually per patient.

Researchers also say the higher rates help insurers bankroll low monthly premiums to attract healthy young enrollees.

Leave a comment

Filed under insurance, tax code, HSAs, regulation

The Veterans Health Administration Really Does Offer ‘Lessons’ in ‘Socialized Medicine’ #VHA

From Reason:

How could a bloated government bureaucracy achieve such low-cost success? As we found out recently, it’s by quietly sticking veterans on a waiting list and putting off their treatment for months-sometimes until the patients are far too dead to need much in the way of expensive care. Which is to say, calling it a “success” is stretching the meaning of the word beyond recognition. And, while the White House insists it learned from press reports about the secret waiting lists, Press Secretary Jay Carney acknowledges that the administration long knew about “the backlog and disability claims” that have accumulated in the VHA.

The article begins:

Just a couple of years ago, Paul Krugman pointed to the Veterans Health Administration (VHA) as a “huge policy success story, which offers important lessons for future health reform.” He gloated, “yes, this is ‘socialized medicine.'”

Read more: The Veterans Health Administration Really Does Offer ‘Lessons’ in ‘Socialized Medicine’ – Hit & Run : Reason.com.

Leave a comment

Filed under Medicaid/Medicare/SCHIP

Associated Press: Consumers losing doctors with new insurance plans

From the Associated Press:

[M]ore consumers realize they bought plans with limited doctor and hospital networks, some after websites that mistakenly said their doctors were included.

Before the law took effect, experts warned that narrow networks could impact patient’s access to care, especially in cheaper plans. But with insurance cards now in hand, consumers are finding their access limited across all price ranges.

The dilemma undercuts President Obama’s 2009 pledge that: “If you like your doctor, you will be able to keep your doctor, period.”

More: Consumers losing doctors with new insurance plans – The Washington Post.

Via the NCPA.

Leave a comment

Filed under insurance, tax code, HSAs

Should Doctors Limit Medical Care To Save Money For ‘Society’?

Paul Hsieh, MD writes:

There will always be limits on who will or will not receive expensive medical treatments. We have no choice about that. But we do have a choice of whether those decisions will be made by patients based on their personal and economic priorities — or by government bureaucrats. The first protects the doctor-patient relationship. The second creates divided loyalties for doctors, who will always be serving two masters. As a doctor, I prefer the first. As a patient, you should too.

Read more: Should Doctors Limit Medical Care To Save Money For ‘Society’?.

Leave a comment

Filed under insurance, tax code, HSAs, Medicaid/Medicare/SCHIP, physicians & medical quality

Colorado Health Exchange premiums ~ equal to high-risk pool premiums, and you can’t keep your doctor.

Linda Gorman describes how the so-called Affordable Care Act required one Coloradan to leave Colorado’s high-risk pool for a plan on Colorado’s health insurance exchange, Connect for Health Colorado.  The premiums are similar, but the exchange plan’s a narrow physician network did not include her doctor.  Read more: Colorado Health Exchange Premiums Roughly Equal to Those of High Risk Pool | John Goodman’s Health Policy Blog | NCPA.org.

Leave a comment

Filed under Colorado health care

How the FDA promotes skin cancer

Do you use sunscreen or sunblock? The Washington Post explains how the FDA forces you to use inferior products:

The tourists flocking to the French Riviera or Spain’s Costa del Sol this summer will slather on sunscreen containing the latest ingredients for protecting against the sun’s most harmful ultraviolet rays.

But American beachgoers will have to make do with sunscreens that dermatologists and cancer-research groups say are less effective and have changed little over the past decade.

That’s because applications for the newer sunscreen ingredients have languished for years in the bureaucracy of the Food and Drug Administration, which must approve the products before they reach consumers.

“We have a system here that’s completely broken down, and everybody knows that it has broken down,” said Wendy Selig, president of the Melanoma Research Alliance, the largest private funder of melanoma research.

Via Marginal Revolution: Still Burned by the FDA.

It’s FDA policies like the above that validate my view of the agency as one run by paternalistic overlords.

See also: FDAreview.orgCato on the FDA, “Kill the FDA (Before it Kills Again)“, and this video by economist Dan Klein:

Leave a comment

Filed under regulation